Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Pharmerging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global pharmerging market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 10.4% during 2021-2026. Pharmerging refers to a group of countries that hold low positioning in the pharmaceutical market but have a speedy growth. Some of the key pharmerging markets include China, India, Brazil, Russia, South Africa, Mexico, Indonesia, Turkey, etc.

The increasing healthcare expenditures along with the rising number of private hospitals are currently propelling the global pharmerging market growth. Additionally, the high prevalence of numerous chronic diseases and growing consumer awareness towards early disease detection and treatment procedures are further augmenting the market growth. Moreover, the increasing geriatric population, who are more prone to serious medical conditions, such as dementia, hypertension, cardiac failure, etc., is also bolstering the demand for pharmaceuticals. Additionally, the introduction of government policies and reimbursement schemes across various countries for reducing the cost of treatment for chronic diseases is also propelling the market growth. Moreover, the growing number of insurance companies in the pharmerging countries offering numerous insurance policies to decrease the out-of-the-pocket expenditures is further augmenting the demand of pharmaceuticals in these countries. Apart from this, the rising investments in extensive R&D activities in the fields of biotechnology, immunology, oncology, etc., for the introduction of advanced treatments are also catalyzing the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global pharmerging market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product outlook, indication and distribution channel.

Breakup by Product Outlook:

  • Pharmaceuticals
    • Patented Prescription Drugs 
    • Generic Prescription Drugs
    • OTC Drugs
  • Healthcare
    • Medical Devices
    • Clinical Diagnosis
    • Others
       

Breakup by Indication:

  • Lifestyle Diseases
  • Cancer and Autoimmune Diseases 
  • Infectious Diseases
  • Others
     

Breakup by Distribution Channel:

  • Hospitals
  • Retail Pharmacies
  • Online Stores
  • Others
     

Breakup by Country:

  • Tier I
    • China
  • Tier II
    • India
    • Brazil
    • Russia
    • South Africa
  • Tier II
    • Argentina
    • Mexico
    • Poland
    • Ukraine
    • Turkey
    • Saudi Arabia
    • Egypt
    • Algeria
    • Nigeria
    • Thailand
    • Indonesia
    • Pakistan
    • Others
       

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Sanofi S.A., Pfizer Inc., AstraZeneca Plc, GlaxoSmithKline Plc, F. Hoffmann-La Roche AG (Roche AG), Eli Lilly and Company, Johnson & Johnson, Abbott Laboratories, Novartis AG and Teva Pharmaceutical Limited.

Key Questions Answered in This Report:

  • How has the global pharmerging market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What is the impact of COVID-19 on global pharmerging market?
  • What is the breakup of the market based on the product outlook?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the market?
  • What is the structure of the global pharmerging market and who are the key players?
  • What is the degree of competition in the market?

1    Preface
2    Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Pharmerging Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product
    6.1    Pharmaceutical 
        6.1.1 Market Trends
        6.1.2 Major Types
           6.1.2.1 Patented Prescription Drugs
           6.1.2.2 Generic Prescription Drugs
           6.1.2.3 OTC Drugs
        6.1.3 Market Forecast
    6.2    Healthcare 
        6.2.1 Market Trends
        6.2.2 Major Types
           6.2.2.1 Medical Devices
           6.2.2.2 Clinical Diagnosis
           6.2.2.3 Others
        6.2.3 Market Forecast
7    Market Breakup by Indication
    7.1    Lifestyle Diseases 
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Cancer and Autoimmune Diseases 
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Infectious Diseases 
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Others 
        7.4.1 Market Trends
        7.4.2 Market Forecast
8    Market Breakup by Distribution Channel
    8.1    Hospitals
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Retail Pharmacies
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Online Stores 
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Others 
        8.4.1 Market Trends
        8.4.2 Market Forecast
9    Market Breakup by Country
    9.1    Tier I
        9.1.1 China
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
    9.2    Tier II
        9.2.1 India
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Brazil
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 Russia
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Africa
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
    9.3    Tier III
        9.3.1 Argentina
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 Mexico
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 Poland
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Ukraine
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Turkey
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Saudi Arabia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Egypt
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
        9.3.8 Algeria
           9.3.8.1 Market Trends
           9.3.8.2 Market Forecast
        9.3.9 Nigeria
           9.3.9.1 Market Trends
           9.3.9.2 Market Forecast
        9.3.10 Thailand
           9.3.10.1 Market Trends
           9.3.10.2 Market Forecast
        9.3.11 Indonesia
           9.3.11.1 Market Trends
           9.3.11.2 Market Forecast
        9.3.12 Pakistan
           9.3.12.1 Market Trends
           9.3.12.2 Market Forecast
        9.3.13 Others
           9.3.13.1 Market Trends
           9.3.13.2 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Competitive Landscape
    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    Sanofi S.A.
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio 
           13.3.1.3 Financials
           13.3.1.4 SWOT Analysis
        13.3.2    Pfizer Inc.
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio 
           13.3.2.3 Financials
           13.3.2.4 SWOT Analysis
        13.3.3    AstraZeneca Plc.
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio 
           13.3.3.3 Financials
           13.3.3.4 SWOT Analysis
        13.3.4    GlaxoSmithKline Plc.
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio
           13.3.4.3 Financials
           13.3.4.3 SWOT Analysis
        13.3.5    F. Hoffmann-La Roche AG (Roche AG)
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio 
           13.3.5.3 Financials
           13.3.5.4 SWOT Analysis
        13.3.6    Eli Lilly and Company
           13.3.6.1 Company Overview
           13.3.6.2 Product Portfolio 
           13.3.6.3 Financials
           13.3.6.4 SWOT Analysis
        13.3.7    Johnson & Johnson
           13.3.7.1 Company Overview
           13.3.7.2 Product Portfolio 
           13.3.7.3 Financials
           13.3.7.4 SWOT Analysis
        13.3.8    Abbott Laboratories
           13.3.8.1 Company Overview
           13.3.8.2 Product Portfolio 
           13.3.8.3 Financials
           13.3.8.4 SWOT Analysis
        13.3.9    Novartis AG
           13.3.9.1 Company Overview
           13.3.9.2 Product Portfolio 
           13.3.9.3 Financials
           13.3.9.4 SWOT Analysis
        13.3.10    Teva Pharmaceutical Limited
           13.3.10.1 Company Overview
           13.3.10.2 Product Portfolio 
           13.3.10.3 Financial
           13.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Pharmerging Market: Major Drivers and Challenges
Figure 2: Global: Pharmerging Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Pharmerging Market: Breakup by Product (in %), 2020
Figure 4: Global: Pharmerging Market: Breakup by Indication (in %), 2020
Figure 5: Global: Pharmerging Market: Breakup by Distribution Channel (in %), 2020
Figure 6: Global: Pharmerging Market: Breakup by Country (in %), 2020
Figure 7: Global: Pharmerging Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 8: Global: Pharmerging (Pharmaceuticals) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Pharmerging (Pharmaceuticals) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Pharmerging (Healthcare) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Pharmerging (Healthcare) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Pharmerging (Lifestyle Diseases) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Pharmerging (Lifestyle Diseases) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Pharmerging (Cancer and Autoimmune Diseases) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Pharmerging (Cancer and Autoimmune Diseases) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Pharmerging (Infectious Diseases) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Pharmerging (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Pharmerging (Other Indications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Pharmerging (Other Indications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Pharmerging (Hospitals) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Pharmerging (Hospitals) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Pharmerging (Retail Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Pharmerging (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Pharmerging (Online Stores) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Pharmerging (Online Stores) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Pharmerging (Other Distribution Channels) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Pharmerging (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Tier I: Pharmerging Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Tier I: Pharmerging Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: China: Pharmerging Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: China: Pharmerging Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Tier II: Pharmerging Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Tier II: Pharmerging Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: India: Pharmerging Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: India: Pharmerging Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Brazil: Pharmerging Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Brazil: Pharmerging Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Russia: Pharmerging Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: Russia: Pharmerging Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: South Africa: Pharmerging Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: South Africa: Pharmerging Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Tier III: Pharmerging Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Tier III: Pharmerging Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Argentina: Pharmerging Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Argentina: Pharmerging Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: Mexico: Pharmerging Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: Mexico: Pharmerging Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Poland: Pharmerging Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Poland: Pharmerging Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Ukraine: Pharmerging Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Ukraine: Pharmerging Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: Turkey: Pharmerging Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: Turkey: Pharmerging Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: Saudi Arabia: Pharmerging Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: Saudi Arabia: Pharmerging Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Egypt: Pharmerging Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Egypt: Pharmerging Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: Algeria: Pharmerging Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: Algeria: Pharmerging Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: Nigeria: Pharmerging Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: Nigeria: Pharmerging Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Thailand: Pharmerging Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Thailand: Pharmerging Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Indonesia: Pharmerging Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Indonesia: Pharmerging Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Pakistan: Pharmerging Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Pakistan: Pharmerging Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Others: Pharmerging Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Others: Pharmerging Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Global: Pharmerging Industry: SWOT Analysis
Figure 71: Global: Pharmerging Industry: Value Chain Analysis
Figure 72: Global: Pharmerging Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Pharmerging Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Pharmerging Market Forecast: Breakup by Product Outlook (in Million US$), 2021-2026
Table 3: Global: Pharmerging Market Forecast: Breakup by Indication (in Million US$), 2021-2026
Table 4: Global: Pharmerging Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 5: Global: Pharmerging Market Forecast: Breakup by Country (in Million US$), 2021-2026
Table 6: Global: Pharmerging Market: Competitive Structure
Table 7: Global: Pharmerging Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links